It has been stated as a partial agonist of the acetylcholine muscarinic receptor. It has activity against schizophrenia by directly targeting OLs and also inhibits demyelination of white matter. It increases social and cognitive properties and maintains myelin damage in the cortex by facilitating differentiation of oligodendrocyte precursor cells by dephosphorylating the active protein kinase AMPKα. It demonstrates to enhance body excitability through stimulation of muscarinic receptors as well as enhancing memory and learning abilities. The gene discussed is WEE1; the disease is schizophrenia.